-
Google PR 4Trustworthiness Unknown
-
Avg. Daily Visitors N/AChild Safety Unknown
-
Avg. Daily Pageviews N/APrivacy Unknown
CHC – Coalition For Healthcare Communication
Cohealthcom.org: get to the top rated Cohealthcom pages and content popular with USA-based Cohealthcom.org users or check the following digest to find out more. Cohealthcom.org is a malware-free website without age restrictions, so you can safely browse it. It seems that Cohealthcom team are just starting to conquer the social media and they have already achieved a promising result — 22 user activities so far (LinkedIn dominates with around 98% of all user reactions). Cohealthcom.org is hosted with OLM, LLC in United States. Cohealthcom traffic is not yet estimated by Alexa.Domain info
Location: | United States |
Registrant: | PERFECT PRIVACY, LLC |
Hosted by: | OLM, LLC |
Registrar: | Public Interest Registry |
Subnetworks: | 216.71.118.84 |
Social Media Activities
- Facebook likes: -
- Twitter mentions: -
- Google pluses: -
- LinkedIn mentions: 22
- Pinterest pins: -
- StumbleUpon views: -
Web Safety
- This website is malware-free.
- Status ok
Sites associated with the same registrant
Whois
Cohealthcom.org popular pages to visit
CHC – Coalition For Healthcare Communication
About Us
The Coalition for Healthcare Communication is an organization that promotes the free exchange of scientific and medical information. It is essential that healthcare professionals and the gene...
MIWG Asks FDA to Clarify Position Regarding Manufacturer Dissemination of New Use Information – CHC
Sept. 16, 2013 – The Medical Information Working Group (MIWG), a coalition of medical product manufacturers seeking to improve the regulatory and enforcement environment for communications about new u...
FDA Willing to “Re-examine” Off-label Policies in Light of First Amendment Rulings |
Coalition for Healthcare Communication
April 28, 2014 – The FDA is not taking lightly industry’s concerns that its existing off-label policies are not in line with the most recent First Amendment case law, according to FDA senior officials...